Is ImmunoPrecise Antibodies Ltd. (IPA) a Buy, Sell, or Hold?
NASDAQ : IPA
ImmunoPrecise Antibodies Ltd.
$1.62 USD
$0.04 (2.53%)
- Volume
- 55.66K
- Average Volume
- 2.91M
- Market Capitalization
- $74.77M
- P/E Ratio
- -8.07
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.25
- Year Low
- $0.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.74
Company Overview
NASDAQ
Jennifer Lynne Bath
Biotechnology
Healthcare
IPA
72
CA
USD
Liquidity Metrics
0.24
3.74
3.64
2.80
0.00
Sales & Valuation
$24.52M
5.72
7.08
-8.86
-0.26
Profitability
-$0.91
-$30.23M
-66.38%
-71.69%
-63.40%
-52.72%
P/E Metrics
-8.07
-0.05
-0.05
Analyst Price Target & Rating
0/5
2 Analysts
%
Financial Health Scores
-1.00
4/9
$13.89M
$23.17M
$8.19M
-$12.47M
Key Metrics (TTM)
$94.65M
5.14
-9.29
3.74
-63.40%
-64.92%
-11.51%
-11.28%
-83 days
Company Executives
| Name | Title |
|---|---|
| Ilse Roodink | Chief Scientific Officer & Interim General Manager of IPA Europe, Oss |
| Jennifer Lynne Bath | Chief Executive Officer, President & Non-Independent Director |
| Joseph Scheffler | Interim Chief Financial Officer |
| Kari Graber | Vice President of Commercial Services |
Poll Results
No votes yet today — be the first to share your view!
About ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Stock
ImmunoPrecise Antibodies Ltd. (IPA) is a global biotechnology firm that, through its subsidiaries, focuses on the development and production of antibodies, alongside offering a broad spectrum of related scientific services. Its operational footprint spans across the United States, Canada, Europe, Australia, and other international territories. For the research community, IPA delivers a diverse portfolio of products, including various types of antibodies, enzymes, enzyme activity assays, specialized animal products for arthritis studies, proteins (such as deiminated proteins), organoid growth factors, and hybridoma reagents. As a comprehensive Contract Research Organization (CRO), IPA provides an extensive suite of services covering the entire antibody discovery and development pipeline. Th ... is includes customized antigen design, modeling, and manufacturing; advanced B cell analysis encompassing sorting, screening, and sequencing; the development and screening of custom, immune, and naive phage display libraries; multi-species antibody discovery, including from transgenic animals; and the creation of specialized antibody formats such as bi-specific, tri-specific, VHH, and VNAR (shark) antibodies. Further expertise lies in DNA cloning, protein and antibody downstream processing, label-free biosensor-based antibody characterization, and antibody engineering. They also provide transient and stable cell line generation, antibody optimization and humanization, high-throughput hybridoma production with multiplexed screening and clone selection, and cryopreservation services. The company actively engages in strategic research collaborations, notably partnering with Pierre Fabre S.A. for antibody discovery initiatives. Additionally, it collaborates with Elektrofi, Inc. to investigate a high-concentration formulation for its COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was established in 1983 and maintains its headquarters in Victoria, Canada.
2026-05-18 09:00:00
MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in a
Atlas AI Labs to Launch First Ever Permissionless Asset-Backed Token from Dubai
2026-05-12 09:34:00
Atlas AI Labs to Launch First Ever Permissionless Asset-Backed Token from Dubai PR Newswire DUBAI, UAE, May 12,
Blue Point Brewing Launches Magic Hour IPA—A Bright, Tropical 6% ABV Sipper for Golden Hour
2026-05-12 07:00:00
PATCHOGUE, N.Y., May 12, 2026 (GLOBE NEWSWIRE) -- Blue Point Brewing, a Long Island craft brewery and brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is launching a new year-round offering, Magic Hour IPA.
Frequently Asked Questions
-
What is the current ImmunoPrecise Antibodies Ltd. (IPA) stock price?
-
ImmunoPrecise Antibodies Ltd.(NASDAQ:IPA) stock price is $1.62 in the last trading session. During the trading session, IPA stock reached the peak price of $3.246 while $0.27 was the lowest point it dropped to. The percentage change in IPA stock occurred in the recent session was 2.53% while the dollar amount for the price change in IPA stock was $0.04.
-
IPA's industry and sector of operation?
-
The NASDAQ listed IPA is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of IPA?
-
Ilse Roodink | Chief Scientific Officer & Interim General Manager of IPA Europe, Oss
Jennifer Lynne Bath | Chief Executive Officer, President & Non-Independent Director
Joseph Scheffler | Interim Chief Financial Officer
Kari Graber | Vice President of Commercial Services
| -
How many employees does IPA have?
-
Number of IPA employees currently stands at 72. IPA operates from 3204–4464 Markham Street, Austin, BC V8Z 7X8, CA.
-
Link for IPA official website?
-
Official Website of IPA is: https://www.ipatherapeutics.com
-
How do I contact IPA?
-
IPA could be contacted at phone #250-483-0308 and can also be accessed through its website. IPA operates from 3204–4464 Markham Street, Austin, BC V8Z 7X8, CA.
-
How many shares of IPA are traded daily?
-
The average number of IPA shares traded daily for last 3 months was 2.91M.
-
What is the market cap of IPA currently?
-
The market value of IPA currently stands at $74.77M with its latest stock price at $1.62